CBIO · Categories · Form 4

CBIO - SEC Form 4 insider transactions

Crescent Biopharma Inc. (CBIO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CBIO

• 7d
  SEC Form 4 filed by Director Violin Jonathan

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 7d
  SEC Form 4 filed by Director Lubner David Charles

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 7d
  SEC Form 4 filed by Director Balcom Alexandra

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 7d
  SEC Form 4 filed by Director Moran Susan

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 7d
  SEC Form 4 filed by Director Fairmount Funds Management Llc

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Chief Scientific Officer Pinkas Jan was granted 22,507 units of Ordinary Shares (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Chief Business Officer Doughty Christopher Grant was granted 22,714 units of Ordinary Shares, increasing direct ownership by 58% to 62,194 units (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Chief Executive Officer Brumm Joshua T was granted 55,117 units of Ordinary Shares, increasing direct ownership by 21% to 323,517 units (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Chief Financial Officer Scalzo Richard William was granted 19,422 units of Ordinary Shares (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  President and COO Mcneill Jonathan was granted 25,507 units of Ordinary Shares, increasing direct ownership by 19% to 159,707 units (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Chief Medical Officer Im Ellie Eunkyung was granted 21,298 units of Ordinary Shares (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Officer Lynch Ryan was granted 12,378 units of Ordinary Shares (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 175d
  Officer Bispham Barbara Harlin was granted 18,422 units of Ordinary Shares (SEC Form 4)

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 182d
  SEC Form 4 filed by President and COO Mcneill Jonathan

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 182d
  SEC Form 4 filed by Chief Executive Officer Brumm Joshua T

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 329d
  SEC Form 4 filed by Chief Scientific Officer Pinkas Jan

  4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)
• 931d
  Luo Ying acquired 2,840,376 shares (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 931d
  SEC Form 4 filed by Ye Weiguo

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 931d
  SEC Form 4 filed by Ma Songjiang

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 931d
  SEC Form 4 filed by Chen Ruoyu

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 931d
  Gni Group Ltd. acquired 63,588,119 shares (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 931d
  SEC Form 4 filed by Wu Charles C

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Luo Ying

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Eastling Thomas Wilson

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Usman Nassim

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Ying Han

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Parry Renate

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Chen Ruoyu

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 952d
  SEC Form 4 filed by Carmichael Gordon

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 957d
  Gni Hong Kong Ltd disposed of 5,371,304 shares, closing all direct ownership in the company (SEC Form 4)

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1013d
  SEC Form 4: Miller Seline E. returned 6 units of Series Y Preferred Stock to the company, closing all direct ownership in the company

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1013d
  SEC Form 4: Lawlor Augustine returned 49 units of Series Y Preferred Stock to the company, closing all direct ownership in the company

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1013d
  SEC Form 4: Usman Nassim returned 34 units of Series Y Preferred Stock to the company, closing all direct ownership in the company

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1013d
  SEC Form 4: Gni Group Ltd. returned 6,267 units of Series Y Preferred Stock to the company

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1013d
  SEC Form 4: Hunt Andrea returned 28 units of Series Y Preferred Stock to the company, closing all direct ownership in the company

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1400d
  SEC Form 4: Usman Nassim bought $1,528 worth of shares (3,250 units at $0.47), increasing direct ownership by 15% to 24,541 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1400d
  SEC Form 4: Miller Seline E. bought $1,528 worth of shares (3,250 units at $0.47), increasing direct ownership by 100% to 6,500 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1400d
  SEC Form 4: Blouse Grant E. bought $1,528 worth of shares (3,250 units at $0.47), increasing direct ownership by 53% to 9,417 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1568d
  SEC Form 4 filed by Miller Seline E.

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1568d
  SEC Form 4 filed by Blouse Grant E.

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1575d
  SEC Form 4: Usman Nassim bought $1,495 worth of shares (3,250 units at $0.46), increasing direct ownership by 18% to 21,291 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1575d
  SEC Form 4: Miller Seline E. bought $1,495 worth of shares (3,250 units at $0.46)

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1575d
  SEC Form 4: Blouse Grant E. bought $1,495 worth of shares (3,250 units at $0.46), increasing direct ownership by 111% to 6,167 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1615d
  SEC Form 4: Williams Eddie was granted 12,308 shares, increasing direct ownership by 55% to 34,804 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1615d
  SEC Form 4: Ling Geoffrey M.D. was granted 12,855 shares, increasing direct ownership by 68% to 31,790 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1615d
  SEC Form 4: Hunt Andrea was granted 7,521 shares, increasing direct ownership by 36% to 28,228 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1709d
  SEC Form 4: Williams Eddie was granted 2,980 shares, increasing direct ownership by 15% to 22,496 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1709d
  SEC Form 4: Ling Geoffrey M.D. was granted 2,858 shares, increasing direct ownership by 18% to 18,935 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1709d
  SEC Form 4: Lawlor Augustine was granted 5,839 shares, increasing direct ownership by 31% to 24,573 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1709d
  SEC Form 4: Hunt Andrea was granted 1,824 shares, increasing direct ownership by 10% to 20,707 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1709d
  SEC Form 4: Desouza Errol B was granted 3,588 shares, increasing direct ownership by 14% to 29,801 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1731d
  SEC Form 4 filed by Jew Jeanne Y

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1764d
  SEC Form 4: USMAN NASSIM bought $3,139 worth of Common Stock (867 units at $3.62), increasing direct ownership by 5% to 18,041 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1764d
  SEC Form 4: Levy Howard bought $2,313 worth of Common Stock (639 units at $3.62)

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1764d
  SEC Form 4: Blouse Grant E. bought $4,210 worth of Common Stock (1,163 units at $3.62), increasing direct ownership by 66% to 2,917 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1804d
  SEC Form 4: LAWLOR AUGUSTINE was granted 5,542 units of Common Stock, increasing direct ownership by 42% to 18,734 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1804d
  SEC Form 4 filed by Catalyst Biosciences, Inc.

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1804d
  SEC Form 4 filed by TETLOW SHARON

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1804d
  SEC Form 4: Williams Eddie was granted 1,414 units of Common Stock, increasing direct ownership by 8% to 19,516 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)
• 1804d
  SEC Form 4: Hunt Andrea was granted 2,886 units of Common Stock, increasing direct ownership by 18% to 18,883 units

  4 - CATALYST BIOSCIENCES, INC. (0001124105) (Issuer)

Other CBIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends